Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Cryo-Cell International Inc. (CCEL) had Revenue of $7.93M for the most recently reported fiscal quarter, ending 2025-05-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-05-31

Income Statement Financials
Revenue	$7.93M
Net Income	$0.36M
Cost of Goods Sold	$1.86M
Gross Profit	$6.07M
Operating Expenses	$6.44M
Operating Income	$1.49M
Non-Operating Income/Expense	$-0.92M
Pre-Tax Income	$0.58M
Normalized Pre-Tax Income	$0.95M
Income after Taxes	$0.36M
Income from Continuous Operations	$0.36M
Consolidated Net Income/Loss	$0.36M
Normalized Income after Taxes	$0.88M
EBIT	$1.49M
EBITDA	$1.84M
Weighted-Average Shares Outstanding (Basic)	8.08M
Weighted-Average Shares Outstanding (Diluted)	8.13M
Earnings per Share (EPS) (Basic)	$0.04
Earnings per Share (EPS) (Diluted)	$0.04
Balance Sheet Financials
Current Assets	$13.05M
Property, Plant, and Equipment	$21.39M
Long-Term Assets	$51.38M
Total Assets	$64.44M
Current Liabilities	$21.75M
Long-Term Debt	$8.24M
Long-Term Liabilities	$58.25M
Total Liabilities	$80.00M
Common Equity	$-15.56M
Tangible Shareholders Equity	$-18.39M
Shareholders Equity	$-15.56M
Common Shares Outstanding	8.06M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.66M
Cash Flow from Investing Activities	$-1.79M
Cash Flow from Financial Activities	$-0.29M
Beginning Cash	$0.56M
End Cash	$0.14M
Increase/Decrease in Cash	$-0.42M
Stock-Based Compensation	--
Common Stock Dividends Paid	$-3.23M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.60
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	-1.13
Debt to Equity Ratio	-0.97
Gross Margin	76.58%
Operating Margin	18.83%
EBIT Margin	18.83%
EBITDA Margin	--
Pre-Tax Profit Margin	7.25%
Profit Margin	4.49%
Free Cash Flow	$1.65M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.12
Inventory Turnover	2.74
Receiveable Turnover	1.14
Days Sales in Receivables	78.68
Return on Equity	-2.29%
Return on Tangible Equity	-1.93%
Return on Assets	0.55%
Return on Investments	-4.86%
Book Value Per Share	$-1.93
Free Cash Flow per Share	$0.20
Operating Cash Flow per Share	$0.20

Data from Zacks Investment Research, Inc.